Penumbra, Inc Variable Lease, Cost
Penumbra, Inc (PEN) reported Variable Lease, Cost of $11.39 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-02-25
- Penumbra, Inc variable lease, cost for the quarter ending 2022-12-31 was $2.54M, a 11.80% increase year-over-year.
- Penumbra, Inc variable lease, cost for the quarter ending 2022-09-30 was $2.54M, a 58.71% increase year-over-year.
- Penumbra, Inc variable lease, cost for the quarter ending 2022-06-30 was $2.57M, a 89.38% increase year-over-year.
- Penumbra, Inc variable lease, cost for the quarter ending 2022-03-31 was $2.36M, a 60.86% increase year-over-year.
- Penumbra, Inc variable lease, cost for fiscal 2025 was $11.39M, a 1.49% increase from fiscal 2024.
- Penumbra, Inc variable lease, cost for fiscal 2024 was $11.22M, a 3.57% increase from fiscal 2023.
- Penumbra, Inc variable lease, cost for fiscal 2023 was $10.84M, a 8.22% increase from fiscal 2022.
- Penumbra, Inc variable lease, cost for fiscal 2022 was $10.01M, a 49.46% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $11.39M 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $11.22M 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $10.84M 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $5.08M derived: sum of 2 quarters · filed 2025-02-18 | $7.65M derived: sum of 3 quarters · filed 2025-02-18 | $10.01M 10-K · filed 2025-02-18 |
| 2022-09-30 | $2.54M 10-Q · filed 2022-11-03 | $5.11M derived: sum of 2 quarters · filed 2022-11-03 | $7.47M 10-Q · filed 2022-11-03 | $9.74M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $2.57M 10-Q · filed 2022-08-05 | $4.93M 10-Q · filed 2022-08-05 | $7.20M derived: sum of 3 quarters · filed 2024-02-22 | $8.80M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $2.36M 10-Q · filed 2022-05-03 | $4.63M derived: sum of 2 quarters · filed 2024-02-22 | $6.24M derived: sum of 3 quarters · filed 2024-02-22 | $7.59M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $3.87M derived: sum of 2 quarters · filed 2024-02-22 | $5.23M derived: sum of 3 quarters · filed 2024-02-22 | $6.70M 10-K · filed 2024-02-22 |
| 2021-09-30 | $1.60M 10-Q · filed 2022-11-03 | $2.96M derived: sum of 2 quarters · filed 2022-11-03 | $4.43M 10-Q · filed 2022-11-03 | $5.51M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $1.36M 10-Q · filed 2022-08-05 | $2.83M 10-Q · filed 2022-08-05 | $3.91M derived: sum of 3 quarters · filed 2023-02-23 | $5.25M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.47M 10-Q · filed 2022-05-03 | $2.55M derived: sum of 2 quarters · filed 2023-02-23 | $3.89M derived: sum of 3 quarters · filed 2023-02-23 | $5.33M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.42M derived: sum of 2 quarters · filed 2023-02-23 | $3.86M derived: sum of 3 quarters · filed 2023-02-23 | $5.14M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.34M 10-Q · filed 2021-11-03 | $2.78M derived: sum of 2 quarters · filed 2021-11-03 | $4.06M 10-Q · filed 2021-11-03 | $5.12M derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $1.44M 10-Q · filed 2020-08-03 | $2.89M 10-Q · filed 2020-08-03 | $3.78M derived: sum of 3 quarters · filed 2021-02-23 | $4.86M derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-03-31 | $1.45M 10-Q · filed 2020-05-07 | $2.34M derived: sum of 2 quarters · filed 2021-02-23 | $3.42M derived: sum of 3 quarters · filed 2021-02-23 | $4.27M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-12-31 | $884.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $1.97M derived: sum of 2 quarters · filed 2021-02-23 | $2.81M derived: sum of 3 quarters · filed 2021-02-23 | $3.57M 10-K · filed 2021-02-23 |
| 2019-09-30 | $1.08M 10-Q · filed 2019-11-07 | $1.93M derived: sum of 2 quarters · filed 2020-08-03 | $2.69M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $846.00K 10-Q · filed 2020-08-03 | $1.60M 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $758.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |